Dexcom Promotes Jereme Sylvain to Chief Operating Officer
Dexcom expands CFO Jereme Sylvain’s responsibilities to include COO oversight of global operations and quality as it pursues its next growth phase.
Mr. Sylvain joined Dexcom in 2018 and has served as Executive Vice President and Chief Financial Officer since 2021. Throughout his tenure at Dexcom, Mr. Sylvain has built a strong finance leadership team and guided the company’s journey of growth and margin expansion. He has also demonstrated the ability to align and execute cross-functionally, bringing the combination of strategic judgment, operational discipline, and commitment to customers that are key for Dexcom’s next phase of growth and scale.
“Jereme is an exceptional leader and a valued strategic partner across Dexcom,” said Jake Leach, President and CEO. “His deep understanding of our business, operational discipline and customer focus make him the right leader for this expanded role. I am confident that Jereme will help us scale more effectively as we advance our goal to empower millions more people to take control of health.”
About Dexcom
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit Dexcom.com.
Category: IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20260914303235/en/
Media Contact
Nadia Conard
mediarelations@dexcom.com
Investor Contact
Sean Christensen
investor-relations@dexcom.com
Source: DexCom, Inc.